Novo Nordisk released results from a clinical trial March 5 that showed Ozempic reduced the risk of kidney disease-related events in patients with Type 2 diabetes.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Ozempic cuts risk of kidney problems in diabetes patients: New data
